The effect of glucocorticoids on tendon cell viability in human tendon explants
Background and purpose Previous studies on the culture of human tenocytes have shown that dexamethasone and triamcino-lone reduce cell viability, suppress cell proliferation, and reduce collagen synthesis. However, such cell cultures lack the extracellular matrix and three-dimensional structure of n...
Saved in:
Published in | Acta orthopaedica Vol. 80; no. 3; pp. 363 - 367 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Basingstoke
Informa UK Ltd
2009
Taylor & Francis Informa Healthcare |
Subjects | |
Online Access | Get full text |
ISSN | 1745-3674 1745-3682 |
DOI | 10.3109/17453670902988386 |
Cover
Loading…
Abstract | Background and purpose Previous studies on the culture of human tenocytes have shown that dexamethasone and triamcino-lone reduce cell viability, suppress cell proliferation, and reduce collagen synthesis. However, such cell cultures lack the extracellular matrix and three-dimensional structure of normal tendons, which affects their response to stimuli. We established a human tendon explant culture system and tested the effects of dexamethasone and triamcinolone on cell viability.
Methods Primary human tendon explant cultures were prepared from healthy hamstring tendons. Tendon strips were harvested from hamstring tendons and cultured in 24-well plates in Dulbecco’s modification of Eagle’s Medium (DMEM) supplemented with 2% fetal calf serum. The tendon explants were treated with 0 μM (control), 10 μM, or 100 μM dexamethasone sodium phosphate or 0 μM (control), 10 μM, or 100 μM triamcinolone acetonide in DMEM for 96 h. Cell viability was measured by Alamar blue assay before and after glucocorticoid treatment.
Results Incubation with 10 μM and 100 μM dexamethasone reduced cell viability in human tendon explants by 35% and 45%, respectively, as compared to a 6% increase in the controls (p = 0.01, mixed-effects ANOVA). Triamcinolone at 10 μM and 100 μM reduced cell viability by 33% and 36%, respectively, as compared to a 9% increase in the controls (p = 0.07, mixed-effects ANOVA).
Interpretation Human tendon explant cultures can be used to study the effects of glucocorticoids on human tendon. Dexamethasone and triamcinolone suppress the cell viability of human tendon in its natural 3-dimensional environment with matrix anchorage. Human tendon explant cultures provide a species-specific model for further investigation of the effects of glucocorticoids on the metabolism of the extracellular matrix of human tendon, and on its mechanical properties. |
---|---|
AbstractList | Background and purpose
Previous studies on the culture of human tenocytes have shown that dexamethasone and triamcino-lone reduce cell viability, suppress cell proliferation, and reduce collagen synthesis. However, such cell cultures lack the extracellular matrix and three-dimensional structure of normal tendons, which affects their response to stimuli. We established a human tendon explant culture system and tested the effects of dexamethasone and triamcinolone on cell viability.
Methods
Primary human tendon explant cultures were prepared from healthy hamstring tendons. Tendon strips were harvested from hamstring tendons and cultured in 24-well plates in Dulbecco’s modification of Eagle’s Medium (DMEM) supplemented with 2% fetal calf serum. The tendon explants were treated with 0 μM (control), 10 μM, or 100 μM dexamethasone sodium phosphate or 0 μM (control), 10 μM, or 100 μM triamcinolone acetonide in DMEM for 96 h. Cell viability was measured by Alamar blue assay before and after glucocorticoid treatment.
Results
Incubation with 10 μM and 100 μM dexamethasone reduced cell viability in human tendon explants by 35% and 45%, respectively, as compared to a 6% increase in the controls (p = 0.01, mixed-effects ANOVA). Triamcinolone at 10 μM and 100 μM reduced cell viability by 33% and 36%, respectively, as compared to a 9% increase in the controls (p = 0.07, mixed-effects ANOVA).
Interpretation
Human tendon explant cultures can be used to study the effects of glucocorticoids on human tendon. Dexamethasone and triamcinolone suppress the cell viability of human tendon in its natural 3-dimensional environment with matrix anchorage. Human tendon explant cultures provide a species-specific model for further investigation of the effects of glucocorticoids on the metabolism of the extracellular matrix of human tendon, and on its mechanical properties. Previous studies on the culture of human tenocytes have shown that dexamethasone and triamcinolone reduce cell viability, suppress cell proliferation, and reduce collagen synthesis. However, such cell cultures lack the extracellular matrix and three-dimensional structure of normal tendons, which affects their response to stimuli. We established a human tendon explant culture system and tested the effects of dexamethasone and triamcinolone on cell viability.BACKGROUND AND PURPOSEPrevious studies on the culture of human tenocytes have shown that dexamethasone and triamcinolone reduce cell viability, suppress cell proliferation, and reduce collagen synthesis. However, such cell cultures lack the extracellular matrix and three-dimensional structure of normal tendons, which affects their response to stimuli. We established a human tendon explant culture system and tested the effects of dexamethasone and triamcinolone on cell viability.Primary human tendon explant cultures were prepared from healthy hamstring tendons. Tendon strips were harvested from hamstring tendons and cultured in 24-well plates in Dulbecco's modification of Eagle's Medium (DMEM) supplemented with 2% fetal calf serum. The tendon explants were treated with 0 microM (control), 10 microM, or 100 microM dexamethasone sodium phosphate or 0 microM (control), 10 microM, or 100 microM triamcinolone acetonide in DMEM for 96 h. Cell viability was measured by Alamar blue assay before and after glucocorticoid treatment.METHODSPrimary human tendon explant cultures were prepared from healthy hamstring tendons. Tendon strips were harvested from hamstring tendons and cultured in 24-well plates in Dulbecco's modification of Eagle's Medium (DMEM) supplemented with 2% fetal calf serum. The tendon explants were treated with 0 microM (control), 10 microM, or 100 microM dexamethasone sodium phosphate or 0 microM (control), 10 microM, or 100 microM triamcinolone acetonide in DMEM for 96 h. Cell viability was measured by Alamar blue assay before and after glucocorticoid treatment.Incubation with 10 microM and 100 microM dexamethasone reduced cell viability in human tendon explants by 35% and 45%, respectively, as compared to a 6% increase in the controls (p = 0.01, mixed-effects ANOVA). Triamcinolone at 10 microM and 100 microM reduced cell viability by 33% and 36%, respectively, as compared to a 9% increase in the controls (p = 0.07, mixed-effects ANOVA).RESULTSIncubation with 10 microM and 100 microM dexamethasone reduced cell viability in human tendon explants by 35% and 45%, respectively, as compared to a 6% increase in the controls (p = 0.01, mixed-effects ANOVA). Triamcinolone at 10 microM and 100 microM reduced cell viability by 33% and 36%, respectively, as compared to a 9% increase in the controls (p = 0.07, mixed-effects ANOVA).Human tendon explant cultures can be used to study the effects of glucocorticoids on human tendon. Dexamethasone and triamcinolone suppress the cell viability of human tendon in its natural 3-dimensional environment with matrix anchorage. Human tendon explant cultures provide a species-specific model for further investigation of the effects of glucocorticoids on the metabolism of the extracellular matrix of human tendon, and on its mechanical properties.INTERPRETATIONHuman tendon explant cultures can be used to study the effects of glucocorticoids on human tendon. Dexamethasone and triamcinolone suppress the cell viability of human tendon in its natural 3-dimensional environment with matrix anchorage. Human tendon explant cultures provide a species-specific model for further investigation of the effects of glucocorticoids on the metabolism of the extracellular matrix of human tendon, and on its mechanical properties. Previous studies on the culture of human tenocytes have shown that dexamethasone and triamcinolone reduce cell viability, suppress cell proliferation, and reduce collagen synthesis. However, such cell cultures lack the extracellular matrix and three-dimensional structure of normal tendons, which affects their response to stimuli. We established a human tendon explant culture system and tested the effects of dexamethasone and triamcinolone on cell viability. Primary human tendon explant cultures were prepared from healthy hamstring tendons. Tendon strips were harvested from hamstring tendons and cultured in 24-well plates in Dulbecco's modification of Eagle's Medium (DMEM) supplemented with 2% fetal calf serum. The tendon explants were treated with 0 microM (control), 10 microM, or 100 microM dexamethasone sodium phosphate or 0 microM (control), 10 microM, or 100 microM triamcinolone acetonide in DMEM for 96 h. Cell viability was measured by Alamar blue assay before and after glucocorticoid treatment. Incubation with 10 microM and 100 microM dexamethasone reduced cell viability in human tendon explants by 35% and 45%, respectively, as compared to a 6% increase in the controls (p = 0.01, mixed-effects ANOVA). Triamcinolone at 10 microM and 100 microM reduced cell viability by 33% and 36%, respectively, as compared to a 9% increase in the controls (p = 0.07, mixed-effects ANOVA). Human tendon explant cultures can be used to study the effects of glucocorticoids on human tendon. Dexamethasone and triamcinolone suppress the cell viability of human tendon in its natural 3-dimensional environment with matrix anchorage. Human tendon explant cultures provide a species-specific model for further investigation of the effects of glucocorticoids on the metabolism of the extracellular matrix of human tendon, and on its mechanical properties. Background and purpose Previous studies on the culture of human tenocytes have shown that dexamethasone and triamcino-lone reduce cell viability, suppress cell proliferation, and reduce collagen synthesis. However, such cell cultures lack the extracellular matrix and three-dimensional structure of normal tendons, which affects their response to stimuli. We established a human tendon explant culture system and tested the effects of dexamethasone and triamcinolone on cell viability. Methods Primary human tendon explant cultures were prepared from healthy hamstring tendons. Tendon strips were harvested from hamstring tendons and cultured in 24-well plates in Dulbecco's modification of Eagle's Medium (DMEM) supplemented with 2% fetal calf serum. The tendon explants were treated with 0 μM (control), 10 μM, or 100 μM dexamethasone sodium phosphate or 0 μM (control), 10 μM, or 100 μM triamcinolone acetonide in DMEM for 96 h. Cell viability was measured by Alamar blue assay before and after glucocorticoid treatment. Results Incubation with 10 μM and 100 μM dexamethasone reduced cell viability in human tendon explants by 35% and 45%, respectively, as compared to a 6% increase in the controls (p = 0.01, mixed-effects ANOVA). Triamcinolone at 10 μM and 100 μM reduced cell viability by 33% and 36%, respectively, as compared to a 9% increase in the controls (p = 0.07, mixed-effects ANOVA). Interpretation Human tendon explant cultures can be used to study the effects of glucocorticoids on human tendon. Dexamethasone and triamcinolone suppress the cell viability of human tendon in its natural 3-dimensional environment with matrix anchorage. Human tendon explant cultures provide a species-specific model for further investigation of the effects of glucocorticoids on the metabolism of the extracellular matrix of human tendon, and on its mechanical properties. |
Author | Lui, Wai Ting Chuen Fu, Sai Man Lee, Kwong Wan Nar Wong, Margaret |
Author_xml | – sequence: 1 givenname: Margaret surname: Wan Nar Wong fullname: Wan Nar Wong, Margaret email: mwnwong@cuhk.edu.hk organization: 1Department of Orthopaedics, Traumatology Shatin, Shatin, Hong Kong – sequence: 2 givenname: Wai Ting surname: Lui fullname: Lui, Wai Ting email: mwnwong@cuhk.edu.hk organization: 1Department of Orthopaedics, Traumatology Shatin, Shatin, Hong Kong – sequence: 3 givenname: Sai surname: Chuen Fu fullname: Chuen Fu, Sai email: mwnwong@cuhk.edu.hk organization: 1Department of Orthopaedics, Traumatology Shatin, Shatin, Hong Kong – sequence: 4 givenname: Kwong surname: Man Lee fullname: Man Lee, Kwong email: mwnwong@cuhk.edu.hk organization: 1Department of Orthopaedics, Traumatology Shatin, Shatin, Hong Kong |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21669022$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19421908$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kcuKFDEUhoOMOBd9ADdSG3HVmkulkkIRZPAGA7MZ1-FUKpnKkE7aJDXab2-a7ikchd7khJzvP5f85-gkxGAQeknwW0Zw_46IlrNO4B7TXkomuyfobPe2Yp2kJ8tdtKfoPOc7jJlse_wMnZK-paTH8gxd30ymMdYaXZpom1s_66hjKk5HN-YmhqaYMNagjffNvYPBeVe2jQvNNK9hSZvfGw-h5OfoqQWfzYtDvEA_vny-ufy2urr--v3y09VKc96VFddMCwmG4NZoUw8GVtCBj1JorqUBzkUnOgBrta07MtuPuNUDHqSkuOPsAn3c193Mw9qM2oSSwKtNcmtIWxXBqceZ4CZ1G-8VlZRRQmqBN4cCKf6cTS5q7fJuSQgmzlkJ1laQt20lX_3daunx8IkVeH0AIGvwNkHQLi8cJV1XHaKVE3tOp5hzMlZpV6C4uJvQeUWw2tmq_rO1Ksk_ymWII5oPe40LNqY1_IrJj6rA1sf0MCI7Jn__SD4Z8GXSkIy6i3MK1dwjzf8AzXDKRg |
CitedBy_id | crossref_primary_10_1302_0301_620X_94B6_29063 crossref_primary_10_1002_jor_22193 crossref_primary_10_3928_01477447_20120327_22 crossref_primary_10_1002_jor_24451 crossref_primary_10_1186_s12891_016_1328_9 crossref_primary_10_2460_ajvr_79_2_199 crossref_primary_10_1177_0363546516664161 crossref_primary_10_1177_03635465221145949 crossref_primary_10_1097_JSM_0000000000000603 crossref_primary_10_1136_annrheumdis_2012_203146 crossref_primary_10_1080_03008207_2018_1501040 crossref_primary_10_1210_en_2010_1087 crossref_primary_10_1302_2046_3758_312_2000321 crossref_primary_10_1016_j_jse_2011_11_009 crossref_primary_10_1080_14740338_2017_1276561 crossref_primary_10_1039_C6RA23620K crossref_primary_10_1007_s00132_009_1490_y crossref_primary_10_1016_j_jot_2016_08_002 crossref_primary_10_1155_2020_8832218 crossref_primary_10_1302_2046_3758_81_BJR_2018_0181_R1 crossref_primary_10_1016_j_jsbmb_2015_04_010 crossref_primary_10_2106_JBJS_RVW_19_00052 crossref_primary_10_1259_bjr_20150577 crossref_primary_10_1080_03008207_2019_1700962 crossref_primary_10_1177_039139881203501105 crossref_primary_10_1186_s12891_019_2896_2 crossref_primary_10_1210_jc_2012_1681 crossref_primary_10_3390_ijms20081972 crossref_primary_10_1016_j_biopha_2022_112693 crossref_primary_10_1016_j_pmrj_2016_02_008 crossref_primary_10_3389_fnagi_2016_00186 crossref_primary_10_1016_j_semarthrit_2013_08_006 crossref_primary_10_1186_1476_9255_9_40 crossref_primary_10_1177_1759720X231214903 crossref_primary_10_1016_j_fas_2013_04_009 crossref_primary_10_1038_s41598_020_70994_z |
Cites_doi | 10.1114/1.1567282 10.1042/bj2460589 10.1016/S1385-299X(97)00045-7 10.1097/01.blo.0000118184.83983.65 10.1016/S0021-9258(18)41617-1 10.1002/jor.1100160512 10.2106/00004623-199511000-00006 10.1002/jor.1100090406 10.2106/00004623-200310000-00008 10.1002/(SICI)1097-4652(199701)170:1<69::AID-JCP8>3.0.CO;2-J 10.1042/bj1950573 10.1016/0167-4781(91)90082-W 10.1677/joe.0.1420571 10.1007/BF00614309 10.1097/00003086-199611000-00032 10.1080/00016470152846646 10.3109/03008208609017470 |
ContentType | Journal Article |
Copyright | 2009 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2009 2009 INIST-CNRS Copyright: © Nordic Orthopedic Federation 2009 |
Copyright_xml | – notice: 2009 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2009 – notice: 2009 INIST-CNRS – notice: Copyright: © Nordic Orthopedic Federation 2009 |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.3109/17453670902988386 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1745-3682 |
EndPage | 367 |
ExternalDocumentID | PMC2823211 19421908 21669022 10_3109_17453670902988386 399010 |
Genre | Research Article Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .55 .GJ 04C 0R~ 0YH 23M 2QV 2WC 34G 36B 39C 3O- 4.4 53G 5GY 5RE 5VS 6J9 6PF AALIY AAUGY AAWTL ABDBF ABNNA ABPTK ACGFO ACGFS ADBBV ADCVX ADRAZ ADRBQ AEGXH AENEX AFFNX AFKVX AJWEG ALMA_UNASSIGNED_HOLDINGS AOIJS AWYRJ BAWUL BCNDV BMSDO C1A CAG COF CS3 DIK DXH E3Z EAP EBC EBD EBS EBX ECF ECT ECV EHN EIHBH EJD EMB EMK EMOBN ENC ENX EPL EPT ESX F5P FRP GROUPED_DOAJ GX1 H13 HYE J.N KQ8 M48 M4Z M~E O5R O5S O9- OK1 P2P Q~Q RDKPK RNS RPM SV3 TFDNU TFL TFMNY TFW TR2 TUS W2D WQ9 X7M ZXP ~1N ACUHS ADOJX TDBHL AAFWJ AAYXX AFPKN CITATION OVT IQODW CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c556t-5c3c78ae104ece04e3af72b5d87c5c8ea557676aaffcf5363f9d04cb0b8820653 |
IEDL.DBID | M48 |
ISSN | 1745-3674 |
IngestDate | Thu Aug 21 18:25:41 EDT 2025 Fri Jul 11 03:40:09 EDT 2025 Mon Jul 21 06:03:15 EDT 2025 Mon Jul 21 09:14:33 EDT 2025 Tue Jul 01 04:04:23 EDT 2025 Thu Apr 24 23:13:06 EDT 2025 Wed Dec 25 09:01:53 EST 2024 Wed Jun 21 13:15:12 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Human Explant Glucocorticoid Viability Orthopedics Tendon |
Language | English |
License | CC BY 4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the source is credited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c556t-5c3c78ae104ece04e3af72b5d87c5c8ea557676aaffcf5363f9d04cb0b8820653 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3109/17453670902988386 |
PMID | 19421908 |
PQID | 734232544 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | pubmed_primary_19421908 informahealthcare_journals_10_3109_17453670902988386 crossref_citationtrail_10_3109_17453670902988386 crossref_primary_10_3109_17453670902988386 pascalfrancis_primary_21669022 proquest_miscellaneous_734232544 informaworld_taylorfrancis_310_3109_17453670902988386 pubmedcentral_primary_oai_pubmedcentral_nih_gov_2823211 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2009-00-00 |
PublicationDateYYYYMMDD | 2009-01-01 |
PublicationDate_xml | – year: 2009 text: 2009-00-00 |
PublicationDecade | 2000 |
PublicationPlace | Basingstoke |
PublicationPlace_xml | – name: Basingstoke – name: England |
PublicationTitle | Acta orthopaedica |
PublicationTitleAlternate | Acta Orthop |
PublicationYear | 2009 |
Publisher | Informa UK Ltd Taylor & Francis Informa Healthcare |
Publisher_xml | – name: Informa UK Ltd – name: Taylor & Francis – name: Informa Healthcare |
References | Yoshikawa Y (CIT0024) 2001; 72 Scott JE (CIT0015) 1986; 14 Tsai WC (CIT0018) 2002; 29 Oikarinen A (CIT0013) 1991; 1089 Abrahamsson SO (CIT0001) 1991; 9 Wiggins ME (CIT0021) 1995; 77 Clark RA (CIT0007) 1997; 170 Nakano T (CIT0012) 1993; 268 Elliott DM (CIT0008) 2003; 31 Yuksel H (CIT0025) 2001; 11 Koob TJ (CIT0010) 1987; 246 CIT0016 Fu SC (CIT0009) 2005 Chan BP (CIT0006) 1998; 16 Voytik-harbin SL (CIT0020) 1998; 30 Chan BP (CIT0005) 1997 Campbell RB (CIT0004) 1996 Bird JLE (CIT0002) 1994; 142 Loew D (CIT0011) 1986; 30 British NATIONAL (CIT0003) 2003 Springer JE (CIT0017) 1998; 2 Vogel KG (CIT0019) 1992; 59 Wong MWN (CIT0023) 2004 Wong MWN (CIT0022) 2003; 85 Pagé B (CIT0014) 1993; 3 9308546 - Clin Orthop Relat Res. 1997 Sep;(342):239-47 9012786 - J Cell Physiol. 1997 Jan;170(1):69-80 9820284 - J Orthop Res. 1998 Sep;16(5):597-603 9630663 - Brain Res Brain Res Protoc. 1998 Jun;2(4):259-63 3709651 - Eur J Clin Pharmacol. 1986;30(2):225-30 1493795 - Eur J Cell Biol. 1992 Dec;59(2):304-13 6459082 - Biochem J. 1981 Jun 1;195(3):573-81 21573387 - Int J Oncol. 1993 Sep;3(3):473-6 2045977 - J Orthop Res. 1991 Jul;9(4):503-15 3689324 - Biochem J. 1987 Sep 15;246(3):589-98 11480607 - Acta Orthop Scand. 2001 Jun;72(3):287-92 12757203 - Ann Biomed Eng. 2003 May;31(5):599-605 14563798 - J Bone Joint Surg Am. 2003 Oct;85-A(10):1914-20 2938882 - Connect Tissue Res. 1986;14(4):267-78 12415599 - J Rheumatol. 2002 Nov;29(11):2397-402 9557942 - In Vitro Cell Dev Biol Anim. 1998 Mar;34(3):239-46 15123960 - Clin Orthop Relat Res. 2004 Apr;(421):277-81 7593077 - J Bone Joint Surg Am. 1995 Nov;77(11):1682-91 8226804 - J Biol Chem. 1993 Oct 25;268(30):22941-7 15685080 - Clin Orthop Relat Res. 2005 Feb;(431):226-32 11831452 - J Investig Allergol Clin Immunol. 2001;11(3):188-92 8913169 - Clin Orthop Relat Res. 1996 Nov;(332):242-53 2025646 - Biochim Biophys Acta. 1991 May 2;1089(1):40-6 7525827 - J Endocrinol. 1994 Sep;142(3):571-9 |
References_xml | – volume: 31 start-page: 599 year: 2003 ident: CIT0008 publication-title: Ann Biomed Engineering doi: 10.1114/1.1567282 – volume: 246 start-page: 589 issue: 3 year: 1987 ident: CIT0010 publication-title: Biochem J doi: 10.1042/bj2460589 – volume: 30 start-page: 354 year: 1998 ident: CIT0020 publication-title: In Vitro Cell Dev Biol-Animal – volume: 2 start-page: 259 year: 1998 ident: CIT0017 publication-title: Brain Res Potocols doi: 10.1016/S1385-299X(97)00045-7 – start-page: 277 issue: 421 year: 2004 ident: CIT0023 publication-title: Clin Orthop doi: 10.1097/01.blo.0000118184.83983.65 – volume: 268 start-page: 22941 year: 1993 ident: CIT0012 publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)41617-1 – volume: 29 start-page: 2397 issue: 11 year: 2002 ident: CIT0018 publication-title: J Rheumatology – volume: 3 start-page: 473 year: 1993 ident: CIT0014 publication-title: Int J Oncol – volume: 16 start-page: 597 year: 1998 ident: CIT0006 publication-title: J Orthop Res doi: 10.1002/jor.1100160512 – volume: 77 start-page: 1682 year: 1995 ident: CIT0021 publication-title: J Bone Joint Surg (Am) doi: 10.2106/00004623-199511000-00006 – volume: 9 start-page: 503 issue: 4 year: 1991 ident: CIT0001 publication-title: J Orthop Res doi: 10.1002/jor.1100090406 – start-page: 226 issue: 431 year: 2005 ident: CIT0009 publication-title: Clin Orthop – volume: 85 start-page: 1914 year: 2003 ident: CIT0022 publication-title: J Bone Joint Surg (Am) doi: 10.2106/00004623-200310000-00008 – volume: 59 start-page: 304 issue: 2 year: 1992 ident: CIT0019 publication-title: Eur J Cell Biol – start-page: 239 issue: 342 year: 1997 ident: CIT0005 publication-title: Clin Orthop – volume: 170 start-page: 69 year: 1997 ident: CIT0007 publication-title: J Cell Physiol doi: 10.1002/(SICI)1097-4652(199701)170:1<69::AID-JCP8>3.0.CO;2-J – ident: CIT0016 doi: 10.1042/bj1950573 – start-page: 345 year: 2003 ident: CIT0003 publication-title: Royal Pharmaceutical Society of Great Britain – volume: 1089 start-page: 40 year: 1991 ident: CIT0013 publication-title: Biochim Biophys Acta doi: 10.1016/0167-4781(91)90082-W – volume: 142 start-page: 571 year: 1994 ident: CIT0002 publication-title: J Endocrinol doi: 10.1677/joe.0.1420571 – volume: 30 start-page: 225 year: 1986 ident: CIT0011 publication-title: Eur J Clin Pharmacol doi: 10.1007/BF00614309 – volume: 11 start-page: 188 year: 2001 ident: CIT0025 publication-title: J Investig Allergol Clin Immunol – start-page: 242 issue: 332 year: 1996 ident: CIT0004 publication-title: Clin Orthop doi: 10.1097/00003086-199611000-00032 – volume: 72 start-page: 287 issue: 3 year: 2001 ident: CIT0024 publication-title: Acta Orthop Scand doi: 10.1080/00016470152846646 – volume: 14 start-page: 267 year: 1986 ident: CIT0015 publication-title: Conn Tiss Res doi: 10.3109/03008208609017470 – reference: 9820284 - J Orthop Res. 1998 Sep;16(5):597-603 – reference: 2938882 - Connect Tissue Res. 1986;14(4):267-78 – reference: 6459082 - Biochem J. 1981 Jun 1;195(3):573-81 – reference: 8226804 - J Biol Chem. 1993 Oct 25;268(30):22941-7 – reference: 2045977 - J Orthop Res. 1991 Jul;9(4):503-15 – reference: 3689324 - Biochem J. 1987 Sep 15;246(3):589-98 – reference: 12757203 - Ann Biomed Eng. 2003 May;31(5):599-605 – reference: 15123960 - Clin Orthop Relat Res. 2004 Apr;(421):277-81 – reference: 7525827 - J Endocrinol. 1994 Sep;142(3):571-9 – reference: 9308546 - Clin Orthop Relat Res. 1997 Sep;(342):239-47 – reference: 9630663 - Brain Res Brain Res Protoc. 1998 Jun;2(4):259-63 – reference: 12415599 - J Rheumatol. 2002 Nov;29(11):2397-402 – reference: 21573387 - Int J Oncol. 1993 Sep;3(3):473-6 – reference: 7593077 - J Bone Joint Surg Am. 1995 Nov;77(11):1682-91 – reference: 3709651 - Eur J Clin Pharmacol. 1986;30(2):225-30 – reference: 1493795 - Eur J Cell Biol. 1992 Dec;59(2):304-13 – reference: 2025646 - Biochim Biophys Acta. 1991 May 2;1089(1):40-6 – reference: 14563798 - J Bone Joint Surg Am. 2003 Oct;85-A(10):1914-20 – reference: 11831452 - J Investig Allergol Clin Immunol. 2001;11(3):188-92 – reference: 9557942 - In Vitro Cell Dev Biol Anim. 1998 Mar;34(3):239-46 – reference: 9012786 - J Cell Physiol. 1997 Jan;170(1):69-80 – reference: 11480607 - Acta Orthop Scand. 2001 Jun;72(3):287-92 – reference: 8913169 - Clin Orthop Relat Res. 1996 Nov;(332):242-53 – reference: 15685080 - Clin Orthop Relat Res. 2005 Feb;(431):226-32 |
SSID | ssj0038490 |
Score | 2.082941 |
Snippet | Background and purpose Previous studies on the culture of human tenocytes have shown that dexamethasone and triamcino-lone reduce cell viability, suppress cell... Previous studies on the culture of human tenocytes have shown that dexamethasone and triamcinolone reduce cell viability, suppress cell proliferation, and... Background and purpose Previous studies on the culture of human tenocytes have shown that dexamethasone and triamcino-lone reduce cell viability, suppress cell... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref informaworld informahealthcare |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 363 |
SubjectTerms | Biological and medical sciences Cell Survival - drug effects Cells, Cultured Dexamethasone - pharmacology Diseases of the osteoarticular system Glucocorticoids - pharmacology Humans Medical sciences Tendons - cytology Tendons - drug effects Tendons - metabolism Triamcinolone - pharmacology |
Title | The effect of glucocorticoids on tendon cell viability in human tendon explants |
URI | https://www.tandfonline.com/doi/abs/10.3109/17453670902988386 https://www.ncbi.nlm.nih.gov/pubmed/19421908 https://www.proquest.com/docview/734232544 https://pubmed.ncbi.nlm.nih.gov/PMC2823211 |
Volume | 80 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LT-MwEB7xuOwFgYAlC1Q-cFopS4jtxDkghBAIIcFethK3yHFsUalKoC0r-PfMOA8oFLikkTyTtJ6xPN94-g3AgSmiIhHOhoJHJV4yG6oE7zJtSx4bFVvfM_L6JrkciqtbebsEXXurdgKnC6Ed9ZMaTsZ_nh6eT3DBH3vEGWWHGFRLz0NGdOKKq2QZVnFjSqmTw7XoDxW4Eln7_0gZorxoDjkXP2Jum1pvSUzv-pKsd8SmVFGppziprumGsShcfV91-WYbu1iHtTb-ZKeNw2zAkq024S86C2sqO1jtmC9jR1SKIvWonLK6YpQpxw9K87P_o4bb-5mNKuZ7_HXD9ul-THU1WzC8OP93dhm2nRZCI2UyC6XhJlXaIjazxuKFa5fGhSxVaqRRVkuEJWmitXPG4URxl5WRIDsr4n-XfBtWqrqyO8BQw5UpQu6jQgmUJ_750mCQWGIool0WQNRNbG5aGnLqhjHOEY6QLfIPtgjgd69y33BwfCUsPlgr79zqKzX51qD5zOdLWnOSzqd6gznL918wPkoSlIoDYJ0r5LhyyU66svXjNE-JfJEY4gL42XjG66_LBO4kkQognfOZXoBIwedHqtGdJwdHCM0R1P_6_rW78KM5GqN80h6szCaPdh8jrFkx8JmJgV89L-QPIOU |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+effect+of+glucocorticoids+on+tendon+cell+viability+in+human+tendon+explants&rft.jtitle=Acta+orthopaedica&rft.au=Wong%2C+Margaret+Wan+Nar&rft.au=Lui%2C+Wai+Ting&rft.au=Fu%2C+Sai+Chuen&rft.au=Lee%2C+Kwong+Man&rft.date=2009&rft.issn=1745-3674&rft.volume=80&rft.issue=3&rft.spage=363&rft_id=info:doi/10.3109%2F17453670902988386&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1745-3674&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1745-3674&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1745-3674&client=summon |